Apimeds Pharmaceuticals US (APUS) Market Capitalization (2025 - 2026)
Apimeds Pharmaceuticals US (APUS) recorded Market Capitalization of $13.58 million in Q2 2026, down 25.6% from $18.25 million a year earlier.
Analysis
Apimeds Pharmaceuticals US (APUS) Market Capitalization (2025 - 2026) Analysis & Trends
For FY2025, Apimeds Pharmaceuticals US reported Market Capitalization of $20.62 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,147.42 Bn | 1,116.01 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.36 Bn | 541.89 Bn | 17.26 Bn |
| 3 | AbbVie | 509.56 Bn | 482.67 Bn | 12.70 Bn |
| 4 | Merck | 365.93 Bn | 320.31 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.31 Bn | 261.30 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.52 Bn | 235.20 Bn | 12.86 Bn |
| 7 | Amgen | 235.01 Bn | 190.41 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.77 Bn | 167.97 Bn | 6.22 Bn |
| 9 | Pfizer | 171.91 Bn | 118.56 Bn | 10.94 Bn |
| 10 | Apimeds Pharmaceuticals US | 5.77 Mn | -13.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.58 Mn |
| Dec 31, 2025 | 20.62 Mn |
| Sep 30, 2025 | 22.39 Mn |
| Jun 30, 2025 | 18.25 Mn |
API Access
Apimeds Pharmaceuticals US Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=APUS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "APUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=APUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();